EssilorLuxottica Société anonyme (ESLOY)
USD 139.72
(2.99%)
USD 139.72
(2.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.28 Billion EUR | 6.37% |
| 2022 | 2.15 Billion EUR | 48.62% |
| 2021 | 1.44 Billion EUR | 1603.53% |
| 2020 | 85 Million EUR | -92.11% |
| 2019 | 1.07 Billion EUR | -0.55% |
| 2018 | 1.08 Billion EUR | 37.26% |
| 2017 | 789 Million EUR | -2.95% |
| 2016 | 813 Million EUR | 7.4% |
| 2015 | 757 Million EUR | -18.51% |
| 2014 | 929 Million EUR | 56.66% |
| 2013 | 593 Million EUR | 1.54% |
| 2012 | 584 Million EUR | 15.5% |
| 2011 | 505.61 Million EUR | 9.45% |
| 2010 | 461.96 Million EUR | 18.25% |
| 2009 | 390.68 Million EUR | 2.18% |
| 2008 | 382.35 Million EUR | 4.26% |
| 2007 | 366.74 Million EUR | 11.56% |
| 2006 | 328.73 Million EUR | 14.18% |
| 2005 | 287.91 Million EUR | 17.79% |
| 2004 | 244.42 Million EUR | 8.13% |
| 2003 | 226.05 Million EUR | 13.34% |
| 2002 | 199.44 Million EUR | 21.55% |
| 2001 | 164.07 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 682.5 Million EUR | 0.0% |
| 2024 Q1 | 682.5 Million EUR | -26.45% |
| 2023 Q4 | 928 Million EUR | 100.0% |
| 2023 FY | 2.28 Billion EUR | 6.37% |
| 2023 Q1 | 680.5 Million EUR | -30.49% |
| 2023 Q2 | 1.36 Billion EUR | 100.0% |
| 2023 Q3 | 464 Million EUR | -65.91% |
| 2022 Q2 | 1.17 Billion EUR | 100.0% |
| 2022 FY | 2.15 Billion EUR | 48.62% |
| 2022 Q1 | 587 Million EUR | -3.61% |
| 2022 Q3 | 489 Million EUR | -58.35% |
| 2022 Q4 | 979 Million EUR | 100.2% |
| 2021 Q3 | 297 Million EUR | -65.22% |
| 2021 FY | 1.44 Billion EUR | 1603.53% |
| 2021 Q1 | 427 Million EUR | -14.08% |
| 2021 Q2 | 854 Million EUR | 100.0% |
| 2021 Q4 | 609 Million EUR | 105.05% |
| 2020 FY | 85 Million EUR | -92.11% |
| 2020 Q1 | -206 Million EUR | -151.24% |
| 2020 Q2 | -412 Million EUR | -100.0% |
| 2020 Q3 | 248.5 Million EUR | 160.32% |
| 2020 Q4 | 497 Million EUR | 100.0% |
| 2019 Q3 | 203 Million EUR | -69.93% |
| 2019 FY | 1.07 Billion EUR | -0.55% |
| 2019 Q2 | 675 Million EUR | 101.19% |
| 2019 Q1 | 335.5 Million EUR | 21.34% |
| 2019 Q4 | 402 Million EUR | 98.03% |
| 2018 Q1 | 265 Million EUR | -18.59% |
| 2018 Q3 | 276.5 Million EUR | 4.34% |
| 2018 Q4 | 276.5 Million EUR | 0.0% |
| 2018 FY | 1.08 Billion EUR | 37.26% |
| 2018 Q2 | 265 Million EUR | 0.0% |
| 2017 Q3 | 325.5 Million EUR | 67.35% |
| 2017 Q2 | 194.5 Million EUR | 0.0% |
| 2017 Q1 | 194.5 Million EUR | -2.02% |
| 2017 FY | 789 Million EUR | -2.95% |
| 2017 Q4 | 325.5 Million EUR | 0.0% |
| 2016 Q2 | 208 Million EUR | 0.0% |
| 2016 FY | 813 Million EUR | 7.4% |
| 2016 Q4 | 198.5 Million EUR | 0.0% |
| 2016 Q3 | 198.5 Million EUR | -4.57% |
| 2016 Q1 | 208 Million EUR | 12.74% |
| 2015 Q4 | 184.5 Million EUR | 0.0% |
| 2015 Q2 | 194 Million EUR | 0.0% |
| 2015 Q1 | 194 Million EUR | 68.7% |
| 2015 FY | 757 Million EUR | -18.51% |
| 2015 Q3 | 184.5 Million EUR | -4.9% |
| 2014 Q3 | 115 Million EUR | -67.1% |
| 2014 FY | 929 Million EUR | 56.66% |
| 2014 Q1 | 349.5 Million EUR | 147.0% |
| 2014 Q4 | 115 Million EUR | 0.0% |
| 2014 Q2 | 349.5 Million EUR | 0.0% |
| 2013 Q1 | 155 Million EUR | 0.0% |
| 2013 Q2 | 155 Million EUR | 0.0% |
| 2013 Q3 | 141.5 Million EUR | -8.71% |
| 2013 Q4 | 141.5 Million EUR | 0.0% |
| 2013 FY | 593 Million EUR | 1.54% |
| 2012 FY | 584 Million EUR | 15.5% |
| 2011 FY | 505.61 Million EUR | 9.45% |
| 2010 FY | 461.96 Million EUR | 18.25% |
| 2009 FY | 390.68 Million EUR | 2.18% |
| 2008 FY | 382.35 Million EUR | 4.26% |
| 2007 FY | 366.74 Million EUR | 11.56% |
| 2006 FY | 328.73 Million EUR | 14.18% |
| 2005 FY | 287.91 Million EUR | 17.79% |
| 2004 FY | 244.42 Million EUR | 8.13% |
| 2003 FY | 226.05 Million EUR | 13.34% |
| 2002 FY | 199.44 Million EUR | 21.55% |
| 2001 FY | 164.07 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 247054.071% |
| Ansell Limited | 76.5 Million USD | -2892.157% |
| Ansell Limited | 76.5 Million USD | -2892.157% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -9327.435% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 140508.516% |
| Psykey, Inc. | -1.32 Million USD | 172991.595% |
| ConvaTec Group Plc | 130.3 Million USD | -1656.715% |
| ConvaTec Group Plc | 130.3 Million USD | -1656.715% |
| Encision Inc. | -691.78 Thousand USD | 330984.107% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 1614220.202% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 976777.504% |
| Innovative MedTech Inc. | -7.93 Million USD | 28932.721% |
| LifePoint, Inc. | -15.23 Million USD | 15127.971% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 33707.4% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 483011.392% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 834143.856% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 498762.391% |
| SmileDirectClub, Inc. | -86.4 Million USD | 2749.183% |
| Sector 10, Inc. | 7036.00 USD | -32532589.028% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | -14.341% |
| SheerVision, Inc. | -71.37 Thousand USD | 3207060.323% |
| United Health Products, Inc. | -2.62 Million USD | 87357.607% |
| Vasamed, Inc. | -4.88 Million USD | 46927.503% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 95935.53% |
| Yubo International Biotech Limited | -1.2 Million USD | 190095.559% |